BIOBIOMLEEX KR Logo
CLINICAL PHARMACOLOGY & EXPORT JOURNAL

Veterinary Insights, Clinical Trials & Global Export Regulations

Authoritative clinical monographs, disease management protocols, and international regulatory registration guides published by the BIOBIOMLEEX R&D Complex in Iksan Biovalley, South Korea.

LIVESTOCK PHARMACOLOGY
2025-01-156 min read

Pharmacokinetics of Florfenicol 30% in Bovine Respiratory Disease (BRD): Lung Tissue Penetration & Single-Dose Efficacy

Clinical evaluation of single-dose subcutaneous florfenicol at 40 mg/kg versus divided intramuscular regimens. Analysis of minimum inhibitory concentration (MIC90) against Mannheimia haemolytica and Pasteurella multocida in feedlot cattle.

Takeaway: Subcutaneous administration at 40 mg/kg maintains therapeutic plasma concentrations above 1 µg/mL for 96 continuous hours, eliminating the need for daily handling stress in commercial feedlots.
By R&D Formulation Laboratory, BIOBIOMLEEX KR
POULTRY HEALTH
2025-01-285 min read

Preventing Clostridium perfringens Necrotic Enteritis in Commercial Broilers: Water-Soluble Amoxicillin Protocols

Controlled comparison of water-soluble amoxicillin trihydrate 50% dosing strategies during coccidiosis co-infections. Guidelines for drinking-water acidification and withdrawal schedule tracking.

Takeaway: Administering amoxicillin at 15 mg/kg via pulse dosing within a 4-hour daily window prevents subclinical mucosal sloughing without degrading intestinal water intake.
By Avian Pathology Division, BIOBIOMLEEX KR
REGULATORY COMPLIANCE
2025-02-108 min read

South Korean MFDS Export Certification: Navigating Certificate of Free Sale (CFS) & CTD Module 3 Dossiers

A practical guide for international distributors registering South Korean veterinary pharmaceuticals with local ministries of agriculture in Southeast Asia, the Middle East, and Latin America.

Takeaway: Securing an authentic apostilled Certificate of Free Sale (CFS) from the Korean APQA alongside Zone IVb stability testing reduces import approval timelines by 4 to 6 months.
By Global Regulatory Affairs Desk, BIOBIOMLEEX KR
COMPANION ANIMAL CARE
2025-02-225 min read

Topical Antifungal & Antibacterial Synergies: Managing Recurrent Malassezia Dermatitis in Canines

Therapeutic protocols combining Chlorhexidine Gluconate 2% and Ketoconazole 1% in companion animal dermatology. Contact time validation and epidermal barrier recovery.

Takeaway: A strict 10-minute lather contact time is mandatory; premature rinsing reduces fungal cell wall disruption by over 60%.
By Companion Clinical Health Section, BIOBIOMLEEX KR